UBASH3A and inflammatory bowel disease: Through the use of a mouse model of inflammatory bowel disease that is driven in part by activated T cells, it was also demonstrated that the lack of either Sts-1 or Sts-2 alone was sufficient to promote increases in cytokine expression and inflammatory pathology [25].